ADP-ribosylation factor 6 expression increase in oesophageal adenocarcinoma suggests a potential biomarker role for it. Kanamarlapudi V, Tamaddon-Jahromi S, Murphy K. PLoS One 2022;17:e0263845.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kanamarlapudi V, Tamaddon-Jahromi S, Murphy K. ADP-ribosylation factor 6 expression increase in oesophageal adenocarcinoma suggests a potential biomarker role for it. PLoS One 2022;17:e0263845.
PMID: 35143561